Indeed, an increasing trend in VTE risk (OR = 1.47, 95% CI: 0.25–8.50) was identified compared with the 5 mg regimen [ 45 ].
← all excerpts
Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery.
1
—
—